Cargando…
A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53
Although ∼50% of all types of human cancers harbour wild-type TP53, this p53 tumour suppressor is often deactivated through a concerted action by its abnormally elevated suppressors, MDM2, MDMX or SIRT1. Here, we report a novel small molecule Inauhzin (INZ) that effectively reactivates p53 by inhibi...
Autores principales: | Zhang, Qi, Zeng, Shelya X, Zhang, Yu, Zhang, Yiwei, Ding, Derong, Ye, Qizhuang, Meroueh, Samy O, Lu, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376857/ https://www.ncbi.nlm.nih.gov/pubmed/22331558 http://dx.doi.org/10.1002/emmm.201100211 |
Ejemplares similares
-
Structure and Activity Analysis of Inauhzin Analogs as Novel Antitumor Compounds That Induce p53 and Inhibit Cell Growth
por: Zhang, Qi, et al.
Publicado: (2012) -
Global Effect of Inauhzin on Human p53-Responsive Transcriptome
por: Liao, Jun-Ming, et al.
Publicado: (2012) -
Determination of maximum tolerated dose and toxicity of Inauhzin in mice
por: Zhang, Qi, et al.
Publicado: (2015) -
Nanoparticle encapsulation of non-genotoxic p53 activator Inauhzin-C for improved therapeutic efficacy
por: Bhattarai, Nimisha, et al.
Publicado: (2021) -
The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress
por: Zhang, Qi, et al.
Publicado: (2014)